🇺🇸 FDA
Patent

US 8398989

Human cystathionine β-synthase variants and methods of production thereof

granted A61KA61K38/00A61P

Quick answer

US patent 8398989 (Human cystathionine β-synthase variants and methods of production thereof) held by The Regents of the University of Colorado expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61P, A61P3/00, A61P43/00